Kura Oncology

KURA • NASDAQ • Stock Fundamentals

Kura Oncology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Troy Edward Wilson, with a market cap of $924.1M.

Market Cap$924.1M

Employees142.0

CEOTroy Edward Wilson

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Kura Oncology

Kura Oncology (KURA) has a market capitalization of $924.1M and trades on NASDAQ.

Kura Oncology has approximately 142 employees.